Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2025/04/084358
CTRI/2025/04/084358Not yet recruitingPhase 4

A comparative clinical study to evaluate the effect of Shadushan Guggulu and Triphala kwath in the management of Medoroga w.s.r. to Dyslipidemia

Prof Dr Vijay Chaudhary1 site in 1 country30 target enrollmentStarted: June 20, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To reduce the level of S.Cholesterol level below 200mg/dl
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

At the end of the trial, collected data will be analyzed by using appropriate statistical methods and will be present in the form of thesis.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
30.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients with Serum lipid profile : Serum Cholesterol- 200 to 350 mg/dl Serum Triglycerides.
  • •150 to 350 mg/dl Serum LDL.
  • •100 to 200 mg/dl Serum VLDL.
  • •30 to 100 mg/dl Serum HDL.
  • •20 to 40 mg/dl Patients willing to participate in the trial. Patients between the age group of 30-70 years of either gender will be selected for the study.

Exclusion Criteria

  • •Patient having major illness like Type-II Diabetes mellitus, Carcinoma, advanced Renal and Liver disorders.
  • •Pregnant females and lactating mother.
  • •Patients who has completed participation in any other clinical trial during the past 6 months.

Outcomes

Primary Outcomes

To reduce the level of S.Cholesterol level below 200mg/dl

Time Frame: 3 months

S.Triglycerides level below 150mg/dl

Time Frame: 3 months

S.LDL level below 100mg/dl

Time Frame: 3 months

Secondary Outcomes

  • To assess the clinical safety of Shadushan Guggulu and Triphala Kwath in patients of Medoroga w.s.r. to Dyslipidaemia.(3 months)

Investigators

Sponsor
Prof Dr Vijay Chaudhary
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
Ayurvedic treatment of Paralysis
CTRI/2017/05/008497IPGT RA GAU JAMNAGAR GUJARAT90
Not yet recruiting
Phase 4
An open clinical trial to test the effect of Chirayata [Swertia purpurascens Wall]in the management of Non-Alcoholic Fatty Liver Disease
CTRI/2025/04/084560Prof Dr Vijay Chaudhary30
Not yet recruiting
Phase 2
EFFECT OF AYURVEDIC DRUG, FOMENTATION AND LOCAL STEAM BATH IN JOINT DISORDER
CTRI/2019/11/021868National Institute Of Ayurveda Jaipur60
Not yet recruiting
Phase 3
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis
NCT05731596Tanta University46
Not yet recruiting
Phase 2/3
The study between Nidhigdhikadi syrup and Brihati syrup in dry cough
CTRI/2023/11/059747D chandrashekar60